Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The Contribution of MMP-7 Promoter Polymorphisms in Renal Cell Carcinoma.

In vivo (Athens, Greece) - 1 Jan 2000

Liao Cheng-Hsi, Chang Wen-Shin, Hu Pei-Shin, Wu Hsi-Chin, Hsu Shih-Wei, Liu Yen-Fang, Liu Shih-Ping, Hung Huey-Shan, Bau DA-Tian, Tsai Chia-Wen

Abstract excerpt

BACKGROUND/AIM: Mounting evidence has suggested that polymorphisms in the promoters of matrix metalloproteinase (MMP) genes are associated with the risk of many types of cancer, but no study has ever explored these polymorphisms as biomarkers for renal cell cancer (RCC). Recently, it was suggested that serum MMP-7 levels have both diagnostic and prognostic potential for RCC. In this study, we focused on the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alleles
Share to Biomarkers, Tumor

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Carcinoma, Renal Cell

Share to Genetic Association Studies

Share to Matrix Metalloproteinase 7

Share to Prognosis

Share to Promoter Regions, Genetic

Share to Taiwan

Source

Open in PubMed Open full text

Identifiers

PMID: 28652430
DOI: 10.21873/invivo.11104
PMCID: PMC5566913

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The Contribution of MMP-7 Promoter Polymorphisms in Renal Cell Carcinoma.PMID 28652430Read ↗

The Contribution of Matrix Metalloproteinase-7 Promoter Genotypes in Breast Cancer in Taiwan.Semantic proximity Read ↗

The Contribution of MMP-7 Promoter Polymorphisms to Taiwan Lung Cancer SusceptibilitySemantic proximity Read ↗

No association of MMP-7, MMP-8, and MMP-21 polymorphisms with the risk of hepatocellular carcinoma in a Chinese population.Semantic proximity Read ↗

The Contribution of MMP-7 Genotypes to Colorectal Cancer Susceptibility in Taiwan.Semantic proximity Read ↗

Association of Matrix Metalloproteinase-7 Genotypes to the Risk of Oral Cancer in Taiwan.Semantic proximity Read ↗

The Contribution of Matrix Metalloproteinase-7 Promoter Genotypes to Hepatocellular Carcinoma Susceptibility.Semantic proximity Read ↗

Polymorphisms in the promoter regions of the matrix metalloproteinases-1, -3, -7, and -9 and the risk of epithelial ovarian cancer in China.Semantic proximity Read ↗

The Contribution of MMP-8 Promoter Polymorphisms in Lung Cancer.Semantic proximity Read ↗

The Contribution of Matrix Metalloproteinase-1 Promoter Genotypes in Taiwan Lung Cancer Risk.Semantic proximity Read ↗

The Association of MMP7 Promoter Polymorphisms With Gastric Cancer.Semantic proximity Read ↗

The functional polymorphism in the matrix metalloproteinase-7 promoter increases susceptibility to esophageal squamous cell carcinoma, gastric cardiac adenocarcinoma and non-small cell lung carcinoma.Semantic proximity Read ↗

Association of matrix metalloproteinases 1, 7, and 9 gene polymorphisms with genetic susceptibility to colorectal carcinoma in a Han Chinese population.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.